Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 DSM to Manufacture Novacta Compound for Trials | Contract Pharma

What are you searching for?

Sign in
Breaking News

DSM to Manufacture Novacta Compound for Trials

DSM BioSolutions has entered into an agreement with Novacta Biosystems Ltd. for the process development and cGMP production of its C. difficile molecule, a new class of lantibiotic compounds.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

DSM BioSolutions has entered into an agreement with Novacta Biosystems Ltd. for the process development and cGMP production of its C. difficile molecule, a new class of lantibiotic compounds.

DSM has successfully completed the process development and began cGMP manufacturing of the Novacta compound at its microbial fermentation biotech facility in Capua, Italy. The product will initially be used for preclinical and Phase I trials.

Villaume Kal, vice president of DSM BioSolutions said, “We are excited to work with Novacta Biosystems, an innovative and progressive biopharmaceutical company developing treatments for infectious diseases. Our technology, operational excellence and outstanding cGMP and compliance record with the FDA allows us to serve this important customer and to produce their clinical trial material.”

Mike Dawson, chief scientific officer of Novacta said, “We have chosen to work with DSM as it has an impressive track record for scaling up fermentation processes for antibacterial agents from actinomycetes.”

Financial terms were not disclosed.

Click here to learn more about DSM

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics